A clinical study of dexmedetomidine in perioperative management of burn patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300067780

Enrollment

Unknown

Registered

2023-01-23

Start date

2023-02-15

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation

Interventions

Group D:Dexmedetomidine

Group C:Blank

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing general anesthesia in the burn department; 2. Age > 18 years; 3. ASA I - III, heart function I - II, no serious systemic diseases; 4. Clear awareness and good compliance; 5. Good communication in Mandarin.

Exclusion criteria

Exclusion criteria: 1. Patients with obvious dysfunction of important organs; 2. Nervous and mental system diseases or taking corresponding drugs; 3. Patients with contraindications to the use of commonly used anesthetic drugs.

Design outcomes

Primary

Measure	Time frame
Self-rating anxiety scale;Visual analogue scale for pain;Pupil diameter;	—

Countries

China

Contacts

Public ContactLi Mengmeng

The Fourth Medical Center of PLA General Hospital

mmli304@163.com+86 134 0100 0778

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026